Form 4 for RGNX REGENXBIO Inc.
Accepted 2024-07-30 00:00:00 ET · period of report 2024-07-29 · accession 0001562180-24-005875 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2024-07-30 | 2024-07-29 | RGNX | KARABELAS ARGERIS N | Dir | S - Sale+OE | $15.05 | -11.0K | 11.3K | -49% | -$165.6K |
| DT | 2024-07-30 | 2024-07-29 | RGNX | KARABELAS ARGERIS N | Dir | M - OptEx | $12.74 | +11.0K | 22.3K | +97% | +$140.1K |
| DT | 2024-07-30 | 2024-07-29 | RGNX | KARABELAS ARGERIS N | Dir | M - OptEx | $0.00 | -11.0K | 1,500 | -88% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-29 | S | D | 11,000 | $15.05 | 11,286 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $15.00 to $15.32. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 2 | Common | Common Stock | 2024-07-29 | M | A | 11,000 | $12.74 | 22,286 | D | — | — | |
| 3 | Derivative | Stock Options (Right to Buy) | 2024-07-29 | M | D | 11,000 | $0.00 | 1,500 | D | $12.74 · — to 2026-06-01 | 11,000 Common Stock | (F3) The previously granted option, representing a right to purchase a total of 12,500 shares, became exercisable as follows: the option vested in 12 equal monthly installments following June 1, 2016. |